Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Cytarabine × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 4 Neuroblastoma 2 Meningeal Carcinomatosis 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Vasculitis, Central Nervous System 1 Thrombocytopenia 1 Stiff-Person Syndrome 1 Recurrence 1 Rasmussen subacute encephalitis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neurotoxicity Syndromes 1 Neuromyelitis Optica 1 Neurofibromatosis 1 1 Myasthenia Gravis 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Lambert-Eaton Myasthenic Syndrome 1 Intraocular Lymphoma 1 HIV Infections 1 Ependymoma 1 Drug-Related Side Effects and Adverse Reactions 1 Breast Neoplasms 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

Temozolomide 28 Cyclophosphamide 28 Filgrastim 24 Etoposide 22 Carboplatin 21 Vincristine 17 Cisplatin 17 Radiotherapy 16 Magnetic Resonance Spectroscopy 15 Thiotepa 13 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 Peripheral Blood Stem Cell Transplantation 10 Melphalan 9 Specimen Handling 8 Methotrexate 8 Lomustine 8 Radiation 7 etoposide phosphate 6 X-Rays 6 Topotecan 6 Phantoms, Imaging 6 Biopsy 6 Platinum 5 Nuclear Medicine Department, Hospital 5 Busulfan 5 Bevacizumab 5 1,2-diaminocyclohexaneplatinum II citrate 5 sonidegib 4 sargramostim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡